ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Chemical Drug and Biologic Drug Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-29K13626
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Chemical Drug and Biologic Drug Market Research Report 2023
BUY CHAPTERS

Global Chemical Drug and Biologic Drug Market Research Report 2025

Code: QYRE-Auto-29K13626
Report
May 2025
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Johnson & Johnson
Novartis
Roche
AbbVie
Merck
Bristol–Myers Squibb
GlaxoSmithKline PLC
Pfizer Inc
Sanofi
Takeda
Astrazeneca plc
Bayer
Eli Lilly & Co
Gilead Sciences
Amgen Inc
Novo Nordisk
TEVA
Boehringer Ingelheim
Biogen
Astellas

Chemical Drug and Biologic Drug Market Size

The global market for Chemical Drug and Biologic Drug was valued at US$ 1618440 million in the year 2024 and is projected to reach a revised size of US$ 2266470 million by 2031, growing at a CAGR of 5.0% during the forecast period.

Chemical Drug and Biologic Drug Market

Chemical Drug and Biologic Drug Market

The pharmaceutical industry, it is composed of companies developing and manufacturing innovative medicines and generic pharmaceuticals, as well as over–the-counter drug products. The sector is made up of a number of sub-sectors that service different market segments.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Chemical Drug and Biologic Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chemical Drug and Biologic Drug.
The Chemical Drug and Biologic Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Chemical Drug and Biologic Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chemical Drug and Biologic Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Chemical Drug and Biologic Drug Market Report

Report Metric Details
Report Name Chemical Drug and Biologic Drug Market
Accounted market size in year US$ 1618440 million
Forecasted market size in 2031 US$ 2266470 million
CAGR 5.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Chemical Drug
  • Biologic Drug
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., Bristol Myers Squibb, GlaxoSmithKline, Pfizer, Sanofi, Takeda, AstraZeneca, Bayer, Eli Lilly & Co., Gilead Sciences, Amgen, Novo Nordisk, Teva, Boehringer Ingelheim, Biogen, Astellas
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Chemical Drug and Biologic Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Chemical Drug and Biologic Drug Market growing?

Ans: The Chemical Drug and Biologic Drug Market witnessing a CAGR of 5.0% during the forecast period 2025-2031.

What is the Chemical Drug and Biologic Drug Market size in 2031?

Ans: The Chemical Drug and Biologic Drug Market size in 2031 will be US$ 2266470 million.

Who are the main players in the Chemical Drug and Biologic Drug Market report?

Ans: The main players in the Chemical Drug and Biologic Drug Market are Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., Bristol Myers Squibb, GlaxoSmithKline, Pfizer, Sanofi, Takeda, AstraZeneca, Bayer, Eli Lilly & Co., Gilead Sciences, Amgen, Novo Nordisk, Teva, Boehringer Ingelheim, Biogen, Astellas

What are the Application segmentation covered in the Chemical Drug and Biologic Drug Market report?

Ans: The Applications covered in the Chemical Drug and Biologic Drug Market report are Hospital, Retail Pharmacy, Other

What are the Type segmentation covered in the Chemical Drug and Biologic Drug Market report?

Ans: The Types covered in the Chemical Drug and Biologic Drug Market report are Chemical Drug, Biologic Drug

Recommended Reports

Drug Development

Diagnostics & Testing

Therapeutics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chemical Drug and Biologic Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Chemical Drug
1.2.3 Biologic Drug
1.3 Market by Application
1.3.1 Global Chemical Drug and Biologic Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chemical Drug and Biologic Drug Market Perspective (2020-2031)
2.2 Global Chemical Drug and Biologic Drug Growth Trends by Region
2.2.1 Global Chemical Drug and Biologic Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Chemical Drug and Biologic Drug Historic Market Size by Region (2020-2025)
2.2.3 Chemical Drug and Biologic Drug Forecasted Market Size by Region (2026-2031)
2.3 Chemical Drug and Biologic Drug Market Dynamics
2.3.1 Chemical Drug and Biologic Drug Industry Trends
2.3.2 Chemical Drug and Biologic Drug Market Drivers
2.3.3 Chemical Drug and Biologic Drug Market Challenges
2.3.4 Chemical Drug and Biologic Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chemical Drug and Biologic Drug Players by Revenue
3.1.1 Global Top Chemical Drug and Biologic Drug Players by Revenue (2020-2025)
3.1.2 Global Chemical Drug and Biologic Drug Revenue Market Share by Players (2020-2025)
3.2 Global Chemical Drug and Biologic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Chemical Drug and Biologic Drug Revenue
3.4 Global Chemical Drug and Biologic Drug Market Concentration Ratio
3.4.1 Global Chemical Drug and Biologic Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chemical Drug and Biologic Drug Revenue in 2024
3.5 Global Key Players of Chemical Drug and Biologic Drug Head office and Area Served
3.6 Global Key Players of Chemical Drug and Biologic Drug, Product and Application
3.7 Global Key Players of Chemical Drug and Biologic Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Chemical Drug and Biologic Drug Breakdown Data by Type
4.1 Global Chemical Drug and Biologic Drug Historic Market Size by Type (2020-2025)
4.2 Global Chemical Drug and Biologic Drug Forecasted Market Size by Type (2026-2031)
5 Chemical Drug and Biologic Drug Breakdown Data by Application
5.1 Global Chemical Drug and Biologic Drug Historic Market Size by Application (2020-2025)
5.2 Global Chemical Drug and Biologic Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Chemical Drug and Biologic Drug Market Size (2020-2031)
6.2 North America Chemical Drug and Biologic Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Chemical Drug and Biologic Drug Market Size by Country (2020-2025)
6.4 North America Chemical Drug and Biologic Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chemical Drug and Biologic Drug Market Size (2020-2031)
7.2 Europe Chemical Drug and Biologic Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Chemical Drug and Biologic Drug Market Size by Country (2020-2025)
7.4 Europe Chemical Drug and Biologic Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chemical Drug and Biologic Drug Market Size (2020-2031)
8.2 Asia-Pacific Chemical Drug and Biologic Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Chemical Drug and Biologic Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Chemical Drug and Biologic Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chemical Drug and Biologic Drug Market Size (2020-2031)
9.2 Latin America Chemical Drug and Biologic Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Chemical Drug and Biologic Drug Market Size by Country (2020-2025)
9.4 Latin America Chemical Drug and Biologic Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chemical Drug and Biologic Drug Market Size (2020-2031)
10.2 Middle East & Africa Chemical Drug and Biologic Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Chemical Drug and Biologic Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Chemical Drug and Biologic Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Chemical Drug and Biologic Drug Introduction
11.1.4 Johnson & Johnson Revenue in Chemical Drug and Biologic Drug Business (2020-2025)
11.1.5 Johnson & Johnson Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Chemical Drug and Biologic Drug Introduction
11.2.4 Novartis Revenue in Chemical Drug and Biologic Drug Business (2020-2025)
11.2.5 Novartis Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Chemical Drug and Biologic Drug Introduction
11.3.4 Roche Revenue in Chemical Drug and Biologic Drug Business (2020-2025)
11.3.5 Roche Recent Development
11.4 AbbVie
11.4.1 AbbVie Company Details
11.4.2 AbbVie Business Overview
11.4.3 AbbVie Chemical Drug and Biologic Drug Introduction
11.4.4 AbbVie Revenue in Chemical Drug and Biologic Drug Business (2020-2025)
11.4.5 AbbVie Recent Development
11.5 Merck & Co.
11.5.1 Merck & Co. Company Details
11.5.2 Merck & Co. Business Overview
11.5.3 Merck & Co. Chemical Drug and Biologic Drug Introduction
11.5.4 Merck & Co. Revenue in Chemical Drug and Biologic Drug Business (2020-2025)
11.5.5 Merck & Co. Recent Development
11.6 Bristol Myers Squibb
11.6.1 Bristol Myers Squibb Company Details
11.6.2 Bristol Myers Squibb Business Overview
11.6.3 Bristol Myers Squibb Chemical Drug and Biologic Drug Introduction
11.6.4 Bristol Myers Squibb Revenue in Chemical Drug and Biologic Drug Business (2020-2025)
11.6.5 Bristol Myers Squibb Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Details
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Chemical Drug and Biologic Drug Introduction
11.7.4 GlaxoSmithKline Revenue in Chemical Drug and Biologic Drug Business (2020-2025)
11.7.5 GlaxoSmithKline Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Chemical Drug and Biologic Drug Introduction
11.8.4 Pfizer Revenue in Chemical Drug and Biologic Drug Business (2020-2025)
11.8.5 Pfizer Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Chemical Drug and Biologic Drug Introduction
11.9.4 Sanofi Revenue in Chemical Drug and Biologic Drug Business (2020-2025)
11.9.5 Sanofi Recent Development
11.10 Takeda
11.10.1 Takeda Company Details
11.10.2 Takeda Business Overview
11.10.3 Takeda Chemical Drug and Biologic Drug Introduction
11.10.4 Takeda Revenue in Chemical Drug and Biologic Drug Business (2020-2025)
11.10.5 Takeda Recent Development
11.11 AstraZeneca
11.11.1 AstraZeneca Company Details
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Chemical Drug and Biologic Drug Introduction
11.11.4 AstraZeneca Revenue in Chemical Drug and Biologic Drug Business (2020-2025)
11.11.5 AstraZeneca Recent Development
11.12 Bayer
11.12.1 Bayer Company Details
11.12.2 Bayer Business Overview
11.12.3 Bayer Chemical Drug and Biologic Drug Introduction
11.12.4 Bayer Revenue in Chemical Drug and Biologic Drug Business (2020-2025)
11.12.5 Bayer Recent Development
11.13 Eli Lilly & Co.
11.13.1 Eli Lilly & Co. Company Details
11.13.2 Eli Lilly & Co. Business Overview
11.13.3 Eli Lilly & Co. Chemical Drug and Biologic Drug Introduction
11.13.4 Eli Lilly & Co. Revenue in Chemical Drug and Biologic Drug Business (2020-2025)
11.13.5 Eli Lilly & Co. Recent Development
11.14 Gilead Sciences
11.14.1 Gilead Sciences Company Details
11.14.2 Gilead Sciences Business Overview
11.14.3 Gilead Sciences Chemical Drug and Biologic Drug Introduction
11.14.4 Gilead Sciences Revenue in Chemical Drug and Biologic Drug Business (2020-2025)
11.14.5 Gilead Sciences Recent Development
11.15 Amgen
11.15.1 Amgen Company Details
11.15.2 Amgen Business Overview
11.15.3 Amgen Chemical Drug and Biologic Drug Introduction
11.15.4 Amgen Revenue in Chemical Drug and Biologic Drug Business (2020-2025)
11.15.5 Amgen Recent Development
11.16 Novo Nordisk
11.16.1 Novo Nordisk Company Details
11.16.2 Novo Nordisk Business Overview
11.16.3 Novo Nordisk Chemical Drug and Biologic Drug Introduction
11.16.4 Novo Nordisk Revenue in Chemical Drug and Biologic Drug Business (2020-2025)
11.16.5 Novo Nordisk Recent Development
11.17 Teva
11.17.1 Teva Company Details
11.17.2 Teva Business Overview
11.17.3 Teva Chemical Drug and Biologic Drug Introduction
11.17.4 Teva Revenue in Chemical Drug and Biologic Drug Business (2020-2025)
11.17.5 Teva Recent Development
11.18 Boehringer Ingelheim
11.18.1 Boehringer Ingelheim Company Details
11.18.2 Boehringer Ingelheim Business Overview
11.18.3 Boehringer Ingelheim Chemical Drug and Biologic Drug Introduction
11.18.4 Boehringer Ingelheim Revenue in Chemical Drug and Biologic Drug Business (2020-2025)
11.18.5 Boehringer Ingelheim Recent Development
11.19 Biogen
11.19.1 Biogen Company Details
11.19.2 Biogen Business Overview
11.19.3 Biogen Chemical Drug and Biologic Drug Introduction
11.19.4 Biogen Revenue in Chemical Drug and Biologic Drug Business (2020-2025)
11.19.5 Biogen Recent Development
11.20 Astellas
11.20.1 Astellas Company Details
11.20.2 Astellas Business Overview
11.20.3 Astellas Chemical Drug and Biologic Drug Introduction
11.20.4 Astellas Revenue in Chemical Drug and Biologic Drug Business (2020-2025)
11.20.5 Astellas Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Johnson & Johnson
Novartis
Roche
AbbVie
Merck
Bristol–Myers Squibb
GlaxoSmithKline PLC
Pfizer Inc
Sanofi
Takeda
Astrazeneca plc
Bayer
Eli Lilly & Co
Gilead Sciences
Amgen Inc
Novo Nordisk
TEVA
Boehringer Ingelheim
Biogen
Astellas
List of Tables
 Table 1. Global Chemical Drug and Biologic Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Chemical Drug
 Table 3. Key Players of Biologic Drug
 Table 4. Global Chemical Drug and Biologic Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Chemical Drug and Biologic Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Chemical Drug and Biologic Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Chemical Drug and Biologic Drug Market Share by Region (2020-2025)
 Table 8. Global Chemical Drug and Biologic Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Chemical Drug and Biologic Drug Market Share by Region (2026-2031)
 Table 10. Chemical Drug and Biologic Drug Market Trends
 Table 11. Chemical Drug and Biologic Drug Market Drivers
 Table 12. Chemical Drug and Biologic Drug Market Challenges
 Table 13. Chemical Drug and Biologic Drug Market Restraints
 Table 14. Global Chemical Drug and Biologic Drug Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Chemical Drug and Biologic Drug Market Share by Players (2020-2025)
 Table 16. Global Top Chemical Drug and Biologic Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemical Drug and Biologic Drug as of 2024)
 Table 17. Ranking of Global Top Chemical Drug and Biologic Drug Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Chemical Drug and Biologic Drug Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Chemical Drug and Biologic Drug, Headquarters and Area Served
 Table 20. Global Key Players of Chemical Drug and Biologic Drug, Product and Application
 Table 21. Global Key Players of Chemical Drug and Biologic Drug, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Chemical Drug and Biologic Drug Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Chemical Drug and Biologic Drug Revenue Market Share by Type (2020-2025)
 Table 25. Global Chemical Drug and Biologic Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Chemical Drug and Biologic Drug Revenue Market Share by Type (2026-2031)
 Table 27. Global Chemical Drug and Biologic Drug Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Chemical Drug and Biologic Drug Revenue Market Share by Application (2020-2025)
 Table 29. Global Chemical Drug and Biologic Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Chemical Drug and Biologic Drug Revenue Market Share by Application (2026-2031)
 Table 31. North America Chemical Drug and Biologic Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Chemical Drug and Biologic Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Chemical Drug and Biologic Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Chemical Drug and Biologic Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Chemical Drug and Biologic Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Chemical Drug and Biologic Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Chemical Drug and Biologic Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Chemical Drug and Biologic Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Chemical Drug and Biologic Drug Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Chemical Drug and Biologic Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Chemical Drug and Biologic Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Chemical Drug and Biologic Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Chemical Drug and Biologic Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Chemical Drug and Biologic Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Chemical Drug and Biologic Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Johnson & Johnson Company Details
 Table 47. Johnson & Johnson Business Overview
 Table 48. Johnson & Johnson Chemical Drug and Biologic Drug Product
 Table 49. Johnson & Johnson Revenue in Chemical Drug and Biologic Drug Business (2020-2025) & (US$ Million)
 Table 50. Johnson & Johnson Recent Development
 Table 51. Novartis Company Details
 Table 52. Novartis Business Overview
 Table 53. Novartis Chemical Drug and Biologic Drug Product
 Table 54. Novartis Revenue in Chemical Drug and Biologic Drug Business (2020-2025) & (US$ Million)
 Table 55. Novartis Recent Development
 Table 56. Roche Company Details
 Table 57. Roche Business Overview
 Table 58. Roche Chemical Drug and Biologic Drug Product
 Table 59. Roche Revenue in Chemical Drug and Biologic Drug Business (2020-2025) & (US$ Million)
 Table 60. Roche Recent Development
 Table 61. AbbVie Company Details
 Table 62. AbbVie Business Overview
 Table 63. AbbVie Chemical Drug and Biologic Drug Product
 Table 64. AbbVie Revenue in Chemical Drug and Biologic Drug Business (2020-2025) & (US$ Million)
 Table 65. AbbVie Recent Development
 Table 66. Merck & Co. Company Details
 Table 67. Merck & Co. Business Overview
 Table 68. Merck & Co. Chemical Drug and Biologic Drug Product
 Table 69. Merck & Co. Revenue in Chemical Drug and Biologic Drug Business (2020-2025) & (US$ Million)
 Table 70. Merck & Co. Recent Development
 Table 71. Bristol Myers Squibb Company Details
 Table 72. Bristol Myers Squibb Business Overview
 Table 73. Bristol Myers Squibb Chemical Drug and Biologic Drug Product
 Table 74. Bristol Myers Squibb Revenue in Chemical Drug and Biologic Drug Business (2020-2025) & (US$ Million)
 Table 75. Bristol Myers Squibb Recent Development
 Table 76. GlaxoSmithKline Company Details
 Table 77. GlaxoSmithKline Business Overview
 Table 78. GlaxoSmithKline Chemical Drug and Biologic Drug Product
 Table 79. GlaxoSmithKline Revenue in Chemical Drug and Biologic Drug Business (2020-2025) & (US$ Million)
 Table 80. GlaxoSmithKline Recent Development
 Table 81. Pfizer Company Details
 Table 82. Pfizer Business Overview
 Table 83. Pfizer Chemical Drug and Biologic Drug Product
 Table 84. Pfizer Revenue in Chemical Drug and Biologic Drug Business (2020-2025) & (US$ Million)
 Table 85. Pfizer Recent Development
 Table 86. Sanofi Company Details
 Table 87. Sanofi Business Overview
 Table 88. Sanofi Chemical Drug and Biologic Drug Product
 Table 89. Sanofi Revenue in Chemical Drug and Biologic Drug Business (2020-2025) & (US$ Million)
 Table 90. Sanofi Recent Development
 Table 91. Takeda Company Details
 Table 92. Takeda Business Overview
 Table 93. Takeda Chemical Drug and Biologic Drug Product
 Table 94. Takeda Revenue in Chemical Drug and Biologic Drug Business (2020-2025) & (US$ Million)
 Table 95. Takeda Recent Development
 Table 96. AstraZeneca Company Details
 Table 97. AstraZeneca Business Overview
 Table 98. AstraZeneca Chemical Drug and Biologic Drug Product
 Table 99. AstraZeneca Revenue in Chemical Drug and Biologic Drug Business (2020-2025) & (US$ Million)
 Table 100. AstraZeneca Recent Development
 Table 101. Bayer Company Details
 Table 102. Bayer Business Overview
 Table 103. Bayer Chemical Drug and Biologic Drug Product
 Table 104. Bayer Revenue in Chemical Drug and Biologic Drug Business (2020-2025) & (US$ Million)
 Table 105. Bayer Recent Development
 Table 106. Eli Lilly & Co. Company Details
 Table 107. Eli Lilly & Co. Business Overview
 Table 108. Eli Lilly & Co. Chemical Drug and Biologic Drug Product
 Table 109. Eli Lilly & Co. Revenue in Chemical Drug and Biologic Drug Business (2020-2025) & (US$ Million)
 Table 110. Eli Lilly & Co. Recent Development
 Table 111. Gilead Sciences Company Details
 Table 112. Gilead Sciences Business Overview
 Table 113. Gilead Sciences Chemical Drug and Biologic Drug Product
 Table 114. Gilead Sciences Revenue in Chemical Drug and Biologic Drug Business (2020-2025) & (US$ Million)
 Table 115. Gilead Sciences Recent Development
 Table 116. Amgen Company Details
 Table 117. Amgen Business Overview
 Table 118. Amgen Chemical Drug and Biologic Drug Product
 Table 119. Amgen Revenue in Chemical Drug and Biologic Drug Business (2020-2025) & (US$ Million)
 Table 120. Amgen Recent Development
 Table 121. Novo Nordisk Company Details
 Table 122. Novo Nordisk Business Overview
 Table 123. Novo Nordisk Chemical Drug and Biologic Drug Product
 Table 124. Novo Nordisk Revenue in Chemical Drug and Biologic Drug Business (2020-2025) & (US$ Million)
 Table 125. Novo Nordisk Recent Development
 Table 126. Teva Company Details
 Table 127. Teva Business Overview
 Table 128. Teva Chemical Drug and Biologic Drug Product
 Table 129. Teva Revenue in Chemical Drug and Biologic Drug Business (2020-2025) & (US$ Million)
 Table 130. Teva Recent Development
 Table 131. Boehringer Ingelheim Company Details
 Table 132. Boehringer Ingelheim Business Overview
 Table 133. Boehringer Ingelheim Chemical Drug and Biologic Drug Product
 Table 134. Boehringer Ingelheim Revenue in Chemical Drug and Biologic Drug Business (2020-2025) & (US$ Million)
 Table 135. Boehringer Ingelheim Recent Development
 Table 136. Biogen Company Details
 Table 137. Biogen Business Overview
 Table 138. Biogen Chemical Drug and Biologic Drug Product
 Table 139. Biogen Revenue in Chemical Drug and Biologic Drug Business (2020-2025) & (US$ Million)
 Table 140. Biogen Recent Development
 Table 141. Astellas Company Details
 Table 142. Astellas Business Overview
 Table 143. Astellas Chemical Drug and Biologic Drug Product
 Table 144. Astellas Revenue in Chemical Drug and Biologic Drug Business (2020-2025) & (US$ Million)
 Table 145. Astellas Recent Development
 Table 146. Research Programs/Design for This Report
 Table 147. Key Data Information from Secondary Sources
 Table 148. Key Data Information from Primary Sources
 Table 149. Authors List of This Report


List of Figures
 Figure 1. Chemical Drug and Biologic Drug Picture
 Figure 2. Global Chemical Drug and Biologic Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Chemical Drug and Biologic Drug Market Share by Type: 2024 VS 2031
 Figure 4. Chemical Drug Features
 Figure 5. Biologic Drug Features
 Figure 6. Global Chemical Drug and Biologic Drug Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Chemical Drug and Biologic Drug Market Share by Application: 2024 VS 2031
 Figure 8. Hospital Case Studies
 Figure 9. Retail Pharmacy Case Studies
 Figure 10. Other Case Studies
 Figure 11. Chemical Drug and Biologic Drug Report Years Considered
 Figure 12. Global Chemical Drug and Biologic Drug Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Chemical Drug and Biologic Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Chemical Drug and Biologic Drug Market Share by Region: 2024 VS 2031
 Figure 15. Global Chemical Drug and Biologic Drug Market Share by Players in 2024
 Figure 16. Global Top Chemical Drug and Biologic Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemical Drug and Biologic Drug as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Chemical Drug and Biologic Drug Revenue in 2024
 Figure 18. North America Chemical Drug and Biologic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Chemical Drug and Biologic Drug Market Share by Country (2020-2031)
 Figure 20. United States Chemical Drug and Biologic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Chemical Drug and Biologic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Chemical Drug and Biologic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Chemical Drug and Biologic Drug Market Share by Country (2020-2031)
 Figure 24. Germany Chemical Drug and Biologic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Chemical Drug and Biologic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Chemical Drug and Biologic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Chemical Drug and Biologic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Chemical Drug and Biologic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Chemical Drug and Biologic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Chemical Drug and Biologic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Chemical Drug and Biologic Drug Market Share by Region (2020-2031)
 Figure 32. China Chemical Drug and Biologic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Chemical Drug and Biologic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Chemical Drug and Biologic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Chemical Drug and Biologic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Chemical Drug and Biologic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Chemical Drug and Biologic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Chemical Drug and Biologic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Chemical Drug and Biologic Drug Market Share by Country (2020-2031)
 Figure 40. Mexico Chemical Drug and Biologic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Chemical Drug and Biologic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Chemical Drug and Biologic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Chemical Drug and Biologic Drug Market Share by Country (2020-2031)
 Figure 44. Turkey Chemical Drug and Biologic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Chemical Drug and Biologic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Chemical Drug and Biologic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Johnson & Johnson Revenue Growth Rate in Chemical Drug and Biologic Drug Business (2020-2025)
 Figure 48. Novartis Revenue Growth Rate in Chemical Drug and Biologic Drug Business (2020-2025)
 Figure 49. Roche Revenue Growth Rate in Chemical Drug and Biologic Drug Business (2020-2025)
 Figure 50. AbbVie Revenue Growth Rate in Chemical Drug and Biologic Drug Business (2020-2025)
 Figure 51. Merck & Co. Revenue Growth Rate in Chemical Drug and Biologic Drug Business (2020-2025)
 Figure 52. Bristol Myers Squibb Revenue Growth Rate in Chemical Drug and Biologic Drug Business (2020-2025)
 Figure 53. GlaxoSmithKline Revenue Growth Rate in Chemical Drug and Biologic Drug Business (2020-2025)
 Figure 54. Pfizer Revenue Growth Rate in Chemical Drug and Biologic Drug Business (2020-2025)
 Figure 55. Sanofi Revenue Growth Rate in Chemical Drug and Biologic Drug Business (2020-2025)
 Figure 56. Takeda Revenue Growth Rate in Chemical Drug and Biologic Drug Business (2020-2025)
 Figure 57. AstraZeneca Revenue Growth Rate in Chemical Drug and Biologic Drug Business (2020-2025)
 Figure 58. Bayer Revenue Growth Rate in Chemical Drug and Biologic Drug Business (2020-2025)
 Figure 59. Eli Lilly & Co. Revenue Growth Rate in Chemical Drug and Biologic Drug Business (2020-2025)
 Figure 60. Gilead Sciences Revenue Growth Rate in Chemical Drug and Biologic Drug Business (2020-2025)
 Figure 61. Amgen Revenue Growth Rate in Chemical Drug and Biologic Drug Business (2020-2025)
 Figure 62. Novo Nordisk Revenue Growth Rate in Chemical Drug and Biologic Drug Business (2020-2025)
 Figure 63. Teva Revenue Growth Rate in Chemical Drug and Biologic Drug Business (2020-2025)
 Figure 64. Boehringer Ingelheim Revenue Growth Rate in Chemical Drug and Biologic Drug Business (2020-2025)
 Figure 65. Biogen Revenue Growth Rate in Chemical Drug and Biologic Drug Business (2020-2025)
 Figure 66. Astellas Revenue Growth Rate in Chemical Drug and Biologic Drug Business (2020-2025)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Generic Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Over the Counter Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Super Generic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Prescription Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Inspection System for Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Bulk Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Biopharma Cosmetics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
High throughput Drug Screening Instrument Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug Pharmaceuticals Cosmetics Retail Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Computer Vision in Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Constrained Peptide Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmaceutical Retail Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
AI for Cancer Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmaceuticals and Biotechnology R D Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Specialty Generics Market
Novel Drug Delivery Systems for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Molecular Diagnosis of Tumors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti Hypertensive Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug Delivery Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Medicine Compounding Robot Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Metaproteomics Service Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-5M19888
Thu Oct 02 00:00:00 UTC 2025

Add to Cart

Global Artificial Intelligence in Biomedical Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-33S19787
Thu Oct 02 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Grade Pregelatinized Starch Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-6P20101
Thu Oct 02 00:00:00 UTC 2025

Add to Cart

Global Bupivacaine Extended-Release Liposome Injection Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-10L20096
Thu Oct 02 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions